Jill DeSimone - 01 Mar 2023 Form 3 Insider Report for Kinnate Biopharma Inc.

Role
Director
Signature
/s/ Mark A. Meltz, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
3
Filing time
03 Mar 2023, 16:52:47 UTC
Previous filing
05 Jan 2023
Next filing
14 Jun 2023

No securities are beneficially owned.